Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Acute Respiratory Infections

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 2 · 50%High 0 · 0%

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with steroid (moderate certainty).

1 finding from 1 review

Epinephrine for bronchiolitis 2011 · Cochrane Headline outcomes only
RR 1.08 [0.77, 1.52]
1 study · 399 participants
Moderate

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).

1 finding from 1 review

Epinephrine for bronchiolitis 2011 · Cochrane Headline outcomes only
RR 0.81 [0.63, 1.03]
3 studies · 875 participants
Low

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with salbutamol/albuterol (moderate certainty).

1 finding from 1 review

Epinephrine for bronchiolitis 2011 · Cochrane Headline outcomes only
RR 1.05 [0.71, 1.54]
2 studies · 212 participants
Moderate

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine and steroid may leads to lower admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).

1 finding from 1 review

Epinephrine for bronchiolitis 2011 · Cochrane Headline outcomes only
RR 0.64 [0.44, 0.95]
1 study · 400 participants
Low